Neither. In clinical: trials, carvedilol has significantly better outcomes than either metoprolol (e.g. 3%/yr lower mortality rates continuing for many years) or bisoprolol. Creatinine is quite another issue, produced by all muscle cells, yet used to crudely estimate renal filtering function, not the 4 known responses to carvedilol. Also the clinical trial data for all the Beta blockers is as augmenters to ACEI agents.
Answered 2/17/2016
1.6k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question